Search

Decapod crustacean welfare is not only an ethical consideration for legislative purposes. Under culture and fishery settings, poor environmental conditions and operator practices can cause stress, which compromises the immune system and increases the risk of disease. For finfish, there are established environmental and animal (group, individual) welfare indicators. This is not the case for crabs, lobsters or shrimp. While environment‐based indicators like temperature, pH and oxygen levels are easily transferable, there is no consensus for a common measure of stress to monitor welfare in decapod crustaceans. To address this shortcoming, we conducted a meta‐analysis of the primary literature to test for relationships between haemolymph (blood) condition, for example, levels of glucose, L‐lactate, haemocytes (n = 8), and sources of physical stress, for example, handling, trawling, emersion and transport (n = 12). Despite variations in effect sizes (n = 459), generalised linear mixed models repeatedly ranked L‐lactate (followed by urea and glucose) as the most significant physiological predictor of stress in the haemolymph, with trawling followed closely by emersion as the most impactful stressors. Duration post (stress) exposure, sex (male, female), water temperature and moult stage (pre‐, inter‐, post‐moult) were not associated significantly with stress prediction using the selected biochemical and cellular parameters, however, moult status was undefined in ~48% of literature sources and should be interpreted with caution. We present evidence that quantitating L‐lactate levels in the haemolymph represents a physiologic operational welfare indicator of decapod crustaceans, which complements existing condition/vigour indices. [ABSTRACT FROM AUTHOR]

Palinurids, also known as spiny lobsters, are high‐value seafood, which is economically important for many European and Asian seafood trades. However, the reduction of wild European spiny lobster populations produces a need for developing alternative renewable strategies to meet current and future demands. Aquaculture of spiny lobsters has the potential to become of major economic importance in the coming years with growing markets in Asia, Europe, and America, with Palinurus elephas being a promising candidate species for use in the commercial culture and stock enhancement of natural fisheries. This is due to its shorter larval periods and rapid growth to the critical puerulus stage compared with other spiny lobster species. While we have a basic understanding of the lifecycle and biology of P. elephas, much of this is based on work undertaken on similar species globally. There are many gaps in our knowledge that need to be addressed to make its aquaculture viable with appropriate feeds being an immediate issue as well as many other husbandry‐related factors. Previous studies act as a platform providing a baseline for further research and highlighting constraints. Developments in the use of P. elephas are promising due to realistically bridgeable knowledge gaps, the likelihood of producing sustainable food and the high commercial value of spiny lobsters. This review identifies our present state of knowledge and outlines the scope for further research and necessary technological developments to make it a viable contribution towards crustacean aquaculture in Europe. [ABSTRACT FROM AUTHOR]

Phylum Cnidaria has been an excellent source of natural products, with thousands of metabolites identified. Many of these have not been screened in bioassays. The aim of this study was to explore the potential of 5600 Cnidaria natural products (after excluding those known to derive from microbial symbionts), using a systematic approach based on chemical space, drug-likeness, predicted toxicity, and virtual screens. Previous drug-likeness measures: the rule-of-five, quantitative estimate of drug-likeness (QED), and relative drug likelihoods (RDL) are based on a relatively small number of molecular properties. We augmented this approach using reference drug and toxin data sets defined for 51 predicted molecular properties. Cnidaria natural products overlap with drugs and toxins in this chemical space, although a multivariate test suggests that there are some differences between the groups. In terms of the established drug-likeness measures, Cnidaria natural products have generally lower QED and RDL scores than drugs, with a higher prevalence of metabolites that exceed at least one rule-of-five threshold. An index of drug-likeness that includes predicted toxicity (ADMET-score), however, found that Cnidaria natural products were more favourable than drugs. A measure of the distance of individual Cnidaria natural products to the centre of the drug distribution in multivariate chemical space was related to RDL, ADMET-score, and the number of rule-of-five exceptions. This multivariate similarity measure was negatively correlated with the QED score for the same metabolite, suggesting that the different approaches capture different aspects of the drug-likeness of individual metabolites. The contrasting of different drug similarity measures can help summarise the range of drug potential in the Cnidaria natural product data set. The most favourable metabolites were around 210–265 Da, quite often sesquiterpenes, with a moderate degree of complexity. Virtual screening against cancer-relevant targets found wide evidence of affinities, with Glide scores <−7 in 19% of the Cnidaria natural products. [ABSTRACT FROM AUTHOR]

Phylum Cnidaria has been an excellent source of natural products, with thousands of metabolites identified. Many of these have not been screened in bioassays. The aim of this study was to explore the potential of 5600 Cnidaria natural products (after excluding those known to derive from microbial symbionts), using a systematic approach based on chemical space, drug-likeness, predicted toxicity, and virtual screens. Previous drug-likeness measures: the rule-of-five, quantitative estimate of drug-likeness (QED), and relative drug likelihoods (RDL) are based on a relatively small number of molecular properties. We augmented this approach using reference drug and toxin data sets defined for 51 predicted molecular properties. Cnidaria natural products overlap with drugs and toxins in this chemical space, although a multivariate test suggests that there are some differences between the groups. In terms of the established drug-likeness measures, Cnidaria natural products have generally lower QED and RDL scores than drugs, with a higher prevalence of metabolites that exceed at least one rule-of-five threshold. An index of drug-likeness that includes predicted toxicity (ADMET-score), however, found that Cnidaria natural products were more favourable than drugs. A measure of the distance of individual Cnidaria natural products to the centre of the drug distribution in multivariate chemical space was related to RDL, ADMET-score, and the number of rule-of-five exceptions. This multivariate similarity measure was negatively correlated with the QED score for the same metabolite, suggesting that the different approaches capture different aspects of the drug-likeness of individual metabolites. The contrasting of different drug similarity measures can help summarise the range of drug potential in the Cnidaria natural product data set. The most favourable metabolites were around 210-265 Da, quite often sesquiterpenes, with a moderate degree of complexity. Virtual screening against cancer-relevant targets found wide evidence of affinities, with Glide scores <-7 in 19% of the Cnidaria natural products.